PRINTER'S NO. 784
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE BILL
No.
569
Session of
2019
INTRODUCED BY DeLUCA, MILLARD, McNEILL, OTTEN, HARKINS, KORTZ,
CALTAGIRONE, BARRAR, FREEMAN, HILL-EVANS, DEASY AND
McCLINTON, MARCH 7, 2019
REFERRED TO COMMITTEE ON INSURANCE, MARCH 7, 2019
AN ACT
Amending the act of November 21, 2016 (P.L.1318, No.169),
entitled, "An act providing for pharmacy audit procedures,
for registration of pharmacy benefits managers and auditing
entities, for maximum allowable cost transparency and for
prescription drugs reimbursed under the PACE and PACENET
program; and making related repeals," in PBM cost
transparency requirements, providing for spread pricing.
The General Assembly of the Commonwealth of Pennsylvania
hereby enacts as follows:
Section 1. The act of November 21, 2016 (P.L.1318, No.169),
known as the Pharmacy Audit Integrity and Transparency Act, is
amended by adding a section to read:
Section 703.1. Spread pricing.
(a) Disclosure of multiple source generic list.--A pharmacy
benefit manager shall disclose to a health insurer whether or
not the pharmacy benefit manager uses the same multiple source
generic list when billing a health insurer as it does when
reimbursing a pharmacy.
(b) Disclosure of difference in amounts paid and charged.--
If a pharmacy benefit manager uses more than one multiple source
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
generic list, the pharmacy benefit manager shall disclose to a
health insurer any difference between the amount paid to a
pharmacy and the amount charged to the health insurer.
Section 2. This act shall take effect in 60 days.
20190HB0569PN0784 - 2 -
1
2
3
4